
Episodes

Thursday Oct 27, 2022
Thursday Oct 27, 2022
Creative Biolabs has invited Dr. James Naismith to walk us through the development process of his novel SARS-CoV-2 neutralising sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.
Version: 20241125
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.